ATNM

1.13

6.60% 0.07

Dopo l'orario di chiusura: 1.10 -0.03 -2.65%

Actinium Pharmaceuticals Inc (ATNM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.06

Aprire:

$1.09

Volume 24 ore:

174.29K

Relative Volume:

1.20

Capitalizzazione di mercato:

$35.53M

Reddito:

$90,000

Utile/perdita netta:

$-23.47M

Rapporto P/E:

-1.5023

EPS:

-0.7522

Flusso di cassa netto:

$-22.98M

1 W Prestazione:

+2.73%

1M Prestazione:

-8.87%

6M Prestazione:

-9.60%

1 anno Prestazione:

-22.60%

Intervallo 1D:

$1.05

$1.15

Intervallo di 1 settimana:

$0.95

$1.15

Portata 52W:

$0.7351

$1.74

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Nome

Actinium Pharmaceuticals Inc

Settore

Healthcare (1052)

Industria

Biotechnology (594)

Telefono

646-767-3870

Indirizzo

275 Madison Avenue, 7th Floor, New York, NY

Dipendente

Cinguettio

@actiniumpharma

Prossima data di guadagno

2026-11-13

Ultimi documenti SEC

ATNM's Discussions on Twitter

Compare ATNM vs VRTX, MRNA, REGN, ARGX, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATNM Actinium Pharmaceuticals Inc	1.13	35.53M	90,000	-23.47M	-22.98M	-0.7522
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-07	Downgrade	B. Riley Securities	Buy → Neutral
2024-05-14	Iniziato	Stephens	Overweight
2023-09-06	Iniziato	HSBC Securities	Buy
2023-02-21	Downgrade	William Blair	Outperform → Mkt Perform
2022-09-08	Iniziato	Cantor Fitzgerald	Overweight
2022-08-25	Iniziato	B. Riley Securities	Buy
2020-11-05	Iniziato	Alliance Global Partners	Buy
2017-12-06	Iniziato	B. Riley FBR, Inc.	Buy
2017-10-23	Ripresa	ROTH Capital	Buy
2017-09-14	Iniziato	Maxim Group	Buy
2016-08-25	Iniziato	ROTH Capital	Buy
2016-02-29	Iniziato	H.C. Wainwright	Buy
2015-10-15	Iniziato	FBR Capital	Outperform
2014-10-01	Iniziato	MLV & Co	Buy
2014-07-22	Iniziato	Canaccord Genuity	Buy

Mostra tutto

Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie

Oct 09, 2026

Next Generation Antibody Therapeutics Market, 2nd Edition: Global Industry Trends and Forecast to 2035 | Immunocytokines and Combination Therapies Drive Growth - GlobeNewswire Inc.

Oct 09, 2026

Sep 21, 2026

Actinium Pharmaceuticals (ATNM) Slips 3.28% to $1.18 as Shares Test Mid-Range SupportFibonacci Fan - siam.in

Sep 21, 2026

Sep 18, 2026

Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Eastern Progress

Sep 18, 2026

Sep 15, 2026

ATNM: Initiating Coverage – Diversified Nuclear Medicine Portfolio - finance.yahoo.com

Sep 15, 2026

Sep 04, 2026

Actinium CEO to present at H.C. Wainwright Glob... - Pluang

Sep 04, 2026

Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire

Sep 04, 2026

Actinium Pharmaceuticals (ATNM) grants director new stock awards - Stock Titan

Sep 04, 2026

Actinium Pharmaceuticals (ATNM) grants director $1.00 options and RSUs - stocktitan.net

Sep 04, 2026

Aug 23, 2026

Actinium (ATNM) Update: Slides 1.79% to $1.10 in Latest Trading; Next Test: Traders Can Monitor the $1.04-$1.16 Range in the Latest SessionBreakout Confirmation - vinanet.vn

Aug 23, 2026

Aug 19, 2026

Actinium (ATNM) Chart: Ends Up by 3.24% at $1.11 in Latest Trading; Level Watch: the Supplied Trading Band Runs From $1.05 to $1.17Up Down Ratio - vinanet.vn

Aug 19, 2026

KPTI Stock Price and Chart — NASDAQ:KPTI - TradingView

Aug 19, 2026

ETFs Investing in Actinium Pharmaceuticals, Inc. Stocks - TradingView

Aug 19, 2026

Aug 15, 2026

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS) - The Globe and Mail

Aug 15, 2026

Aug 14, 2026

Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Nigeria

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property And Manufacturing Advances And Provides NYSE American Listing Update - TradingView

Aug 14, 2026

Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com India

Aug 14, 2026

Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Canada

Aug 14, 2026

Actinium Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update - PR Newswire

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update - finance.yahoo.com

Aug 14, 2026

Aug 10, 2026

Actinium Pharmaceuticals (ATNM) Slips 3.4% to $0.77 as Key Support at $0.73 Comes into FocusRelative Volume - vinanet.vn

Aug 10, 2026

Aug 07, 2026

Actinium Pharmaceuticals (ATNM) Institutional Ownership 2026 - MarketBeat

Aug 07, 2026

Aug 05, 2026

Actinium Pharmaceuticals (ATNM) Falls 7.5% to $0.75 as Selling Pressure IntensifiesGrowth ETF - dars.gov.et

Aug 05, 2026

Aug 03, 2026

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) InvestorsLead Plaintiff Deadline on May 27, 2025 - The National Law Review

Aug 03, 2026

Aug 01, 2026

Actinium Pharmaceuticals, Inc. (Delaware) Revenue Breakdown – AMEX:ATNM - TradingView

Aug 01, 2026

Jul 28, 2026

Actinium Pharmaceuticals (ATNM) Hovers Near Support With Modest DeclineBullish Pattern Stocks - vinanet.vn

Jul 28, 2026

Jul 27, 2026

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - The National Law Review

Jul 27, 2026

Jul 26, 2026